Benign prostatic hyperplasia is a common condition, causing symptoms in 75% of men over the age of 70.
To understand the role of a novel treatment for this condition, an understanding of the pathology, approach to diagnosis, and range of existing therapies are important. This article provides a general overview of benign prostatic hyperplasia evaluation and management.
Written by:
Priest R, Garzotto M, Kaufman J. Are you the author?
Dotter Interventional Institute/Oregon Health and Science University Hospital, Portland, OR 97239, USA.
Reference: Tech Vasc Interv Radiol. 2012 Dec;15(4):261-4.
doi: 10.1053/j.tvir.2012.10.001
PubMed Abstract
PMID: 23244721
